Industry: Health Care – Biotechnology: Biological Products (No Diagnostic Substances)
Stock Symbol: COAG – NASDAQ
Animal Usage: Animal Testing
Hemab Therapeutics Holdings, Inc. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.
Supporting Evidence:
The company stated in the following press release that they use animals for drug testing.
“The ability of HMB-001 to accumulate endogenous FVIIa in FVII deficiency was assessed using small interfering RNA (siRNA) to knock down FVII/FVIIa to levels between 10 to 30 percent of normal in animal models (n=3). After continuous, stable knock down, HMB-001 (5 mg/kg) was administered.” Read the following article
Hemab Therapeutics Holdings, Inc. operates as a clinical-stage biotechnology company developing therapies that reimagine the treatment of blood coagulation disorders to sustain life and human resilience in United States of America and Denmark. The company was founded in 2020 and is based in Cambridge, Massachusetts.
Company Website: https://www.hemab.com